The Pre- and Postoperative Prevalence and Risk Factors of ASA Nonresponse in Vascular Surgery

BACKGROUND: An antiplatelet therapy with acetylsalicylic acid (ASA) is prescribed in the prevention of cardiovascular events, but around 24% of ASA takers are resistant to the treatment. AIM: In this prospective, observational cohort study, we aimed to identify the prevalence and risk factors of ASA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazimi, Alia Uzra, Weber, Christian Friedrich, Keese, Michael, Miesbach, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642110/
https://www.ncbi.nlm.nih.gov/pubmed/34609920
http://dx.doi.org/10.1177/10760296211044723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642110/
https://www.ncbi.nlm.nih.gov/pubmed/34609920
http://dx.doi.org/10.1177/10760296211044723

Ejemplares similares